NEW YORK (GenomeWeb) – Agilent Technologies and BioTek Instruments have partnered to develop an integrated product for cellular metabolic analysis and imaging.

Specifically, the companies will integrate Agilent's Seahorse XFe96/XFe24 Analyzers with BioTek's Cytation 1 Cell Imaging Multi-Mode Reader. The combined product will enable a standardized approach to compare XF data sets, improve assay workflow, embed images into WAVE software, and apply normalization values to Seahorse XF measurements.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.